These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intensive glycemic control in type 2 diabetics at high cardiovascular risk: do the benefits justify the risks? Shurraw S; Tonelli M Kidney Int; 2013 Mar; 83(3):346-8. PubMed ID: 23446251 [TBL] [Abstract][Full Text] [Related]
4. Understanding the long-term benefits and dangers of intensive therapy of diabetes. Nathan DM Arch Intern Med; 2012 May; 172(10):769-70. PubMed ID: 22636821 [No Abstract] [Full Text] [Related]
6. The CARI guidelines. Prevention and management of chronic kidney disease in type 2 diabetes. Chadban S; Howell M; Twigg S; Thomas M; Jerums G; Cass A; Campbell D; Nicholls K; Tong A; Mangos G; Stack A; MacIsaac RJ; Girgis S; Colagiuri R; Colagiuri S; Craig J; Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S162-94. PubMed ID: 20591029 [No Abstract] [Full Text] [Related]
7. [Can diabetic nephropathy be prevented? Or what is the point of no return?]. Grimaldi A; Baumelou A Ann Med Interne (Paris); 1987; 138(7):483-5. PubMed ID: 3326450 [No Abstract] [Full Text] [Related]
8. [Angiotensin II antagonist also protects the kidneys. 2 dialysis-free years for diabetics]. MMW Fortschr Med; 2001 Oct; 143(43):50. PubMed ID: 11715881 [No Abstract] [Full Text] [Related]
10. Microalbuminuria and mortality in type 2 diabetes. Strayer SM J Fam Pract; 1998 Aug; 47(2):89-90. PubMed ID: 9722786 [No Abstract] [Full Text] [Related]
11. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Snyder RW; Berns JS Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745 [TBL] [Abstract][Full Text] [Related]
12. Going out to detect incipient diabetic nephropathy rather than waiting until it has supervened--a reversal in policy. Parving HH Nephrol Dial Transplant; 1996 Sep; 11(9):1728-9. PubMed ID: 8918612 [No Abstract] [Full Text] [Related]
13. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus. Postma MJ; de Zeeuw D Nephrol Dial Transplant; 2009 Oct; 24(10):2975-83. PubMed ID: 19605601 [No Abstract] [Full Text] [Related]
14. Selecting the right drug treatment for adults with type 2 diabetes. Montori VM BMJ; 2016 Mar; 352():i1663. PubMed ID: 27029501 [No Abstract] [Full Text] [Related]
15. [The NEPHRODIAB2 randomized trial]. Villar E; Lièvre M; Labeeuw M; Pouteil-Noble C Nephrologie; 2003; 24(6):317-9. PubMed ID: 14584299 [No Abstract] [Full Text] [Related]
16. [Inadequate diabetic treatment worsens glucose control in diabetic patients with chronic renal failure]. Calonge Calzadilla N; Galán González S; Cervera León M; Callís Privat M; Zurita Badosa M; Franquesa Sala L Aten Primaria; 2011 Feb; 43(2):107-8. PubMed ID: 20494485 [No Abstract] [Full Text] [Related]
17. ACE inhibitors as a shield against diabetic nephropathy. Materson BJ Arch Intern Med; 1996 Feb; 156(3):239-40. PubMed ID: 8572832 [No Abstract] [Full Text] [Related]
18. The CARI guidelines. Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes. Chadban S; Howell M; Twigg S; Thomas M; Jerums G; Cass A; Campbell D; Nicholls K; Tong A; Mangos G; Stack A; MacIsaac RJ; Girgis S; Colagiuri R; Colagiuri S; Craig J; Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S195-203. PubMed ID: 20591031 [No Abstract] [Full Text] [Related]
19. Diabetic nephropathy and renal protective agents. Marchiando R; Elston MP S D J Med; 1999 Oct; 52(10):385-6. PubMed ID: 10546516 [No Abstract] [Full Text] [Related]
20. Nephropathy in patients with type 2 diabetes mellitus. Ritz E; Orth SR N Engl J Med; 1999 Oct; 341(15):1127-33. PubMed ID: 10511612 [No Abstract] [Full Text] [Related] [Next] [New Search]